Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
life sciences
national blog main
san diego blog main
san diego top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
gene therapy
nonalcoholic steatohepatitis
cancer immunotherapy
deals
europe blog main
europe top stories
gilead sciences
glaxosmithkline
parkinson's disease
pfizer
philadelphia blog main
philadelphia top stories
What
bio
6
×
cancer
6
×
roundup
amid
bombast
caught
coronavirus
debate
develop
discussion
efforts
meso’s
miss
pandemic
pfizer’s
pharmaceutical
presidential
promise
response
tuesday’s
vaccine
viewers
abbvie’s
ahead
allogene
appetite
approved
biofourmis
black
bread
bucks
butter
buyout
cash
celebrate
chance
combo
companies
corner
crispr
Language
unset
Current search:
bio
×
biotech
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More